OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 88. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Editorial Board	514
Editorial board members	500
Editorial: Ocular drug delivery – Challenges, opportunities, and developments	311
Editorial board members	249
Special Issue (SI) on: Emerging pharmaceutical technologies (From advanced materials & formulations to new processes) for novel dosage development	240
Editorial board members	237
Trends in versatile 2D (sheet/paper-like) nanomaterials for biomedical applications	235
Preface: Phyto-derived nanomedicines for therapeutics, imaging and drug delivery	234
Agony of choice: How anesthetics affect the composition and function of extracellular vesicles	230
Editorial board members	216
Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population	208
Liposomal formulations for treating lysosomal storage disorders	201
Therapeutic potential of pro-resolving mediators in diabetic kidney disease	195
Long-acting inhaled medicines: Present and future	189
The interaction between particles and vascular endothelium in blood flow	187
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis	182
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy	180
Plant-derived nanotherapeutic systems to counter the overgrowing threat of resistant microbes and biofilms	177
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design	170
Cell and biomaterial delivery strategies to induce immune tolerance	166
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	163
Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems	161
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis	154
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders	151
An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view	148

Nanomedicine/materdicine-enabled sonocatalytic therapy	147
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	144
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	139
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology	137
Protein-engineered biomaterials for cartilage therapeutics and repair	137
Advances in bacteria-based therapy for drug delivery	134
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics	134
Jet injectors: Perspectives for small volume delivery with lasers	132
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity	131
Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics	129
Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms	125
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	124
Using bugs as drugs: Administration of bacteria-related microbes to fight cancer	123
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance	123
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe	122
Cellular transformers for targeted therapy	120
The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system	118
Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties	118
Drug delivery for metabolism targeted cancer immunotherapy	114
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases	113
Advanced vaccine delivery	113
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond	111
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine	111
Spectroscopic techniques for monitoring stem cell and organoid proliferation in 3D environments for therapeutic development	110
Revealing the clinical potential of high-resolution organoids	110
Cellular and molecular imaging of CAR-T cell-based immunotherapy	109
Regulation of in vivo delivery of nanomedicines by herbal medicines	109
MicroRNAs and their delivery in diabetic fibrosis	108
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies	107
Prophylactic vaccine delivery systems against epidemic infectious diseases	105
Editorial Board	105
Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]	103
Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds – A perspective	103
3D printing in musculoskeletal interface engineering: Current progress and future directions	102
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	101
The era of nano-bionic: 2D materials for wearable and implantable body sensors	100
Microbubble-assisted ultrasound for inner ear drug delivery	100
Progress of tumor-resident intracellular bacteria for cancer therapy	99
Molecular imaging of innate immunity and immunotherapy	98
Nanovaccines with cell-derived components for cancer immunotherapy	98
Transflammation in tissue regeneration and response to injury: How cell-autonomous inflammatory signaling mediates cell plasticity	98
Smart gating porous particles as new carriers for drug delivery	98
Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers	96
Current and prospective computational approaches and challenges for developing COVID-19 vaccines	95
Supramolecular engineering of hydrogels for drug delivery	95
Extracellular vesicles as delivery systems at nano-/micro-scale	95
Laser ablation: Heating up the anti-tumor response in the intracranial compartment	93
Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers	93
Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseases	93
Targeted to neuronal organelles for CNS drug development	93

Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies	92
Local delivery strategies to restore immune homeostasis in the context of inflammation	92
Inhaled drug delivery for the targeted treatment of asthma	91
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics	91
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier	91
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity	90
Current understandings and clinical translation of nanomedicines for breast cancer therapy	90
Recent advances of smart materials for ocular drug delivery	89
Advances in powder bed fusion 3D printing in drug delivery and healthcare	89
Towards artificial intelligence-enabled extracellular vesicle precision drug delivery	89
Sustained delivery approaches to improving adaptive immune responses	89
Microneedle-Mediated Vaccination: Innovation and Translation	89
Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy	89
Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years	88